EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer
Clinical trial NCT05467748 · RECRUITING
Trial details
- NCT number
- NCT05467748
- Sponsor
- VA Office of Research and Development
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-08
- Primary completion
- 2027-12-08
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.